Navigant Cymetrix Recognized with 2015/2016 Best in KLAS Award for Excellence in Extended Business Office Services
February 04 2016 - 12:00PM
Business Wire
Award identifies outstanding performance of top service
providers based on feedback from leading healthcare
providers
Navigant Cymetrix today announced it has been recognized as a
leading extended business office services provider, receiving the
top-rated score of 92.4 out of 100 in the “2015/2016 Best in KLAS
Awards: Software & Services” report. This is the third year
Navigant Cymetrix has received the Best in KLAS Award for extended
business office services, also ranking first in 2012 and 2013.
“Navigant has expanded our services to offer healthcare clients
solutions that range from strategy through process execution,” said
David Zito, Managing Director and leader of Navigant’s Healthcare
Segment. “We are proud that Navigant Cymetrix continues our
foundational tradition of top tier quality and customer focus.”
As part of its suite of comprehensive revenue cycle management
solutions, Navigant Cymetrix effectively and efficiently optimizes
the performance of its healthcare provider clients through its
extended business office services, including accounts receivable
management, private and government payer account follow up, and
self-pay account resolution.
“It is an honor to continue to receive such high recognition
from our clients,” said David Hampshire, Managing Director and
leader of Navigant’s Healthcare Business Process Management and
Technology Division. “Our end-to-end revenue cycle management
solutions allow healthcare clients to achieve the full potential of
their entire revenue cycle and focus on delivering quality care and
an improved patient experience.”
To determine the annual Best in KLAS ranking, KLAS utilizes both
performance data and customer satisfaction ratings gathered in
interviews from thousands of healthcare executives across the
country.
About Navigant Cymetrix
Navigant Cymetrix, a wholly owned subsidiary of Navigant
Consulting, Inc., provides healthcare organizations and physician
practices with comprehensive revenue cycle management solutions.
Its solutions have the flexibility to accommodate the specific
needs of each client and are designed to achieve high revenue cycle
performance with a seamless process integrating Patient Access
Services, Revenue Integrity Services, Health Information Management
and Patient Financial Services. More information about Navigant
Cymetrix can be found at navigantcymetrix.com.
About KLAS
KLAS is a research and insights firm on a global mission to
improve healthcare delivery by amplifying the provider's voice.
Working with thousands of healthcare professionals and clinicians,
KLAS gathers data and insights on software, services and medical
equipment to deliver timely reports, trends and statistical
overviews. The research directly represents the provider voice and
acts as a catalyst for improving vendor performance.
About Navigant
Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global
professional services firm that helps clients take control of their
future. Navigant’s professionals apply deep industry knowledge,
substantive technical expertise, and an enterprising approach to
help clients build, manage and/or protect their business interests.
With a focus on markets and clients facing transformational change
and significant regulatory or legal pressures, the Firm primarily
serves clients in the healthcare, energy and financial services
industries. Across a range of advisory, consulting, outsourcing,
and technology/analytics services, Navigant’s practitioners bring
sharp insight that pinpoints opportunities and delivers powerful
results. More information about Navigant can be found at
navigant.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160204006140/en/
Navigant Investor RelationsAaron Miles, 312.583.5820orNavigant
Corporate CommunicationsMegan Maupin, 312.583.5703
Navigant Consulting (NYSE:NCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Navigant Consulting (NYSE:NCI)
Historical Stock Chart
From Apr 2023 to Apr 2024